Theratechnologies Inc T.TH

A Good Day for THTX to be Obscure

[SPCEO1]

I brief look at NASH stocks show they are generally down in sympathy with NGM following its exit from the NASH stage. So, for today at least, it is a positive that TH is not identified by the market as a NASH stock. Of course, it is not clear that the market even knows TH exists at all at this point given the tiny trading volume the stock is seeing. 

As the NASH field continues to narrow, the opportunity for TH's differentiated, upstream NASH strategy with a drug already proven to be safe, to be successful commercially is growing. The attractiveness of Egrifta as a drug to test in combination therapy is also greater now. The logical reaction to the NGM news should be a positive for TH. But markets are not usually all that logical. 

MDGL is still the leader in the NASH field and will likely be first to market. It will be interesting to see if it remains independent or is taken out by a larger pharma company. They certainly would need to at least partner in order to be able to market their drug since they are just a research shop. 

As one of th few remaining phase III NASH stocks, you would think TH would soon be getting more attention. Hopefully, LSA can help pull that off and get the trading volume in THTX up to a much higher level as people begin to realize what the company has in NASH, if not in cancer too.

[Dcutter101]

With all the millions of shares bought in last 30 days, by the institutions, it's time for at least a speculative buy recommendation on this news...we should be at its 52-week high on this other drugs failure - so frustrating 

[SPCEO1]

Well, you are assuming that Wall Street uses common sense and that is often a bad assumption. All the NASH stocks get ripped because of one NASH stock's rather unexpected failure even though all the remaining NASH players have one less competitive threat to be concerned about. So, yes the remaining NASH stocks should benefit from NGM's failure but, for today at least, Wall Street is

[scarlet1967]

"remaining HASH" I would love to see the company get valued like other HASH companies.

[SPCEO1]

That would fix things quickly! Sorry for one of many mispellings in my posts!

[Bucknelly21]

This volume is pathetic 

[scarlet1967]

As other NASH companies failing it opens up opportunities for THTX to go after their investors. Many investors stick to the industry they know so get the harmonized protocol concluded have the life science report finalized, attend conferences reach out to the both retail and institutional investors. Leah should do her homework and find out which institutions/analysts have been involved  in

[Scioto]

spot on scarlet.